Published in
Taylor and Francis Group, Amyloid, 3(30), p. 290-296, 2023
DOI: 10.1080/13506129.2023.2169124
Links
Tools
A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosis
Journal article published in 2023 by
Sriram Ravichandran,
Andrew Hall,
Matthew Jenner,
Mamta Garg,
Bhuvan Kishore,
Helen Lachmann,
Julian Gillmore 
,
Alexandra Pitchford,
Jamie B. Oughton,
Shameem Mahmood,
Sajitha Sachchithantham,
Philip Hawkins,
Sarah Brown,
Ashutosh Wechalekar
,
Alexandra Pitchford,
Jamie B. Oughton,
Shameem Mahmood,
Sajitha Sachchithantham,
Philip Hawkins,
Sarah Brown,
Ashutosh Wechalekar
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 